This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Consolidated Q2 revenue rises 52% year on year; margins weaken, operating cash flow is negative
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated quarter ended 30 September 2026: revenue from operations was Rs 1,772.02 lakh, up 51.8% from Rs 1,167.17 lakh a year earlier; profit after tax was Rs 156.37 lakh versus Rs 128.47 lakh. Profit before interest, tax, depreciation and amortisation was 12.6% of revenue, down from 15.1%. Consolidated half-year operating cash flow was negative Rs 221.83 lakh. Board approved Rs 2.50 lakh for a 50-50 renewable energy joint venture.
Strong revenue growth supports sentiment, but lower operating margins and negative half-year operating cash flow could weigh on the stock.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹17.72 Cr | ₹11.67 Cr | +51.8% |
| Operating profit | ₹1.82 Cr | ₹1.41 Cr | +28.9% |
| Profit after tax | ₹1.56 Cr | ₹1.28 Cr | +21.7% |
| EBITDA margin | 12.6% | 15.1% | −2.5 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.